Find and Pitch Jounalists, Get Your Story Covered

Tags: Monoclonal Antibodies Cancer Antibody Research Bispecific Antibodies DLBCL Trials

	Profile	Recent Articles on Subject
1	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	RSV Preventative Monoclonal Antibody Could Reduce Disease Incidence in Preterm, Full-term Infants - 8 days ago ELA026 Receives Orphan Drug Designation to Treat Hemophagocytic Lymphohistiocytosis - 11 days ago
2	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Inebilizumab for Myasthenia Gravis Reduces Steroid Burden - 8 days ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 4 months ago Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years - 11 months ago 'Exploding' Field of Antibody-Drug Conjugates Makes Inroads in Ovarian Cancer - 11 months ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - 12 months ago Anti-TIGIT Drug Fails to Lift Response Rates in Cervical Cancer Trial - 12 months ago The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer - about 1 year ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’ - 21 days ago Merck Picks Up Novel Bispecific Antibody With Potential in Both Cancer & Autoimmune Disease - 3 months ago
4	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 22 days ago Addressing Challenges When Implementing Bispecific Antibodies in Diverse Settings - 5 months ago Addressing the Challenges of Implementing Bispecific Antibodies in Health Care Centers - 7 months ago Managing Adverse Event Profiles for Three Bispecific Antibodies Approved for Lymphoma - 7 months ago
5	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Sustained Disease Control in Adolescent Myasthenia Gravis With FcRn Blocker - 26 days ago Novel Agent Reduces Monthly Migraine Days - 2 months ago
6	Katherine Kahn MedPage Today Physician-Scientist. Studies Long Covid. United States medicineLong Covid	Novel Monoclonal Antibody Protects Infants Against RSV - 27 days ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Expert Discusses Immunotherapy, Antibody Drug Conjugates for Lung Cancer - 2 months ago FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 2 months ago Study: mRNA Technology Holds Potential for Delivery of Tau-Targeting Antibodies - 8 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 9 months ago Biosimilar SB8 Is Comparable to Bevacizumab for Non–Small Cell Lung Cancer - 9 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 12 months ago Study: Monoclonal Antibodies Benefit Those Previously Treated for HIV - about 1 year ago
8	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 2 months ago
9	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	Oncimmune announces new contract with global pharma company - 3 months ago
10	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	New Monoclonal Authorized to Prevent COVID in Immunocompromised People - 8 months ago

Journalists covering Monoclonal Antibodies